RegeneRx Publishes Annual Letter to Shareholders

4/23/19

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today published its annual letter to stockholders on the Company's website at www.regenerx.com.